Open AccessTarget/therapies for chronic recurrent erythema nodosum leprosum
Author(s) -
Pugazhenthan Thangaraju,
Shoban Babu Varthya,
Sajıtha Venkatesan
Publication year - 2020
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_788_19
Subject(s) - leprosy , erythema nodosum , medicine , dermatology , lepromatous leprosy , disease , immunology , complication , surgery
A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and the mental stressors for the possible management strategies.